IBAB Ion Beam Applications SA

IBA – Regulated information

IBA – Regulated information

                                                                                                                  

November 7th, 2025

Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007) (hereinafter, the “Law”).

Under this provision:

 « [...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by category, the number of securities conferring the right to vote and voting rights vote, at the latest at the end of each calendar month in which an increase or a decrease in these numbers occurred.

On each publication referred to in the first paragraph, the issuer also mentions, if applicable, the total number of bonds convertible into securities conferring the right to vote and rights materialized or not by securities to the subscription of securities conferring the right to vote not yet issued, the total number of voting rights that would result from the exercise of these conversion or subscription rights and the total number of shares without voting rights. »

As of today :

Nature of information Remarks
Amount of capital (EUR)42.502.318,54 
Securities with voting rights

=(A)
30.282.218This is the basis for calculating the 30% threshold provided in article 5 of the takeover law of April 1, 2007 (Belgian Gazette 26.IV.2007).
Shares with voting rights30.282.218 
Shares with loyalty voting right (section 28 of the articles of association)

=(B)
10.232.401 
Existing voting rights

=[A-B+(B*2)]
40.514.619This is the denominator under which must be calculated the quota of voting rights that can give rise to notification in accordance with article 6 of the Law.
Bonds convertible into shares (CB)0 
Voting rights that would result of CB conversion0 
Subscription rights (warrants) issued and exercisable0 
Voting rights that would result of warrant conversion0 
Statutory and legal thresholds (section 35 of the articles of association)1%, 2%, 3%, 4%, 5%, 7.5%, 10%, 15%, etc. by 5% thresholdsThese are the thresholds under which the crossing, whether upward or downward (including passive crossing), gives rise to notification in accordance with section 6 or 18, §2, of the Law.

Contact person for threshold crossing notifications: .

Shares endowed with the right to vote in loyalty: registered shares recorded in the share register for at least two consecutive years in the name of their holder (section 28 of the articles of association, in accordance with section 7:53 of the Companies and Associations Code).

Following the introduction of the loyalty voting right by decision of the general meeting of March 10, 2020, the calculation method used by IBA to determine the number of shares with the loyalty voting right at any time is the LIFO method (last in, first out), namely: for the same registered shareholder, the shares which the latter most recently acquired are the first shares which will be deducted from his “basket” of registered shares if he transfer shares thereafter.

Statutory ceiling (section 7, paragraph 1, of the articles of association: “No shareholder may, with companies and persons related to him, participate in the voting at general meetings for a number of votes exceeding 35% of the votes attached to all of the shares with voting rights issued by the company”): currently 35% of 40.514.619, i.e. 14.180.116,65 votes.

ISIN Code : Euronext Brussels BE0003766806



About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: -worldwide.com

Attachment



EN
07/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE

IBA – Regulated information

IBA – Regulated information                                                                                                                   November 7th, 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007) (hereinafter, the “Law”). Under this provision:  « [...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by cate...

 PRESS RELEASE

IBA – Information Réglementée

IBA – Information Réglementée 7 novembre 2025 Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et portant des dispositions diverses (M.B. 12.VI.2007) (ci-après, la « Loi »). En vertu de cette disposition : « [...] l'émetteur publie le total du capital, le nombre total de titres conférant le droit de vote et de droits de vote, ainsi que, par catégorie, le nombre de titres conférant le droit de vote et de droits de vote, au ...

 PRESS RELEASE

IBA integrates Artificial Intelligence Quality Assurance into dosimetr...

IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH Dosimetry portfolio strengthened with Medical Imaging QA and AI validation  Louvain-la-Neuve, Belgium, 03 November 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a world-leading provider of quality assurance (QA) solutions, today announces the acquisition of PhantomX GmbH, expanding IBA’s portfolio in healthcare diagnostics and therapeutic systems enabling artificial intelligence (AI) quality assurance. Found...

 PRESS RELEASE

IBA intègre l’assurance qualité de l’intelligence artificielle dans se...

IBA intègre l’assurance qualité de l’intelligence artificielle dans ses solutions de dosimétrie grâce à l'acquisition de PhantomX GmbH Renforcement du portefeuille de Dosimetry avec l'assurance qualité en imagerie médicale et la validation par IA Louvain-la-Neuve, Belgique, le 3 novembre 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et l'un des principaux fournisseurs de solutions de dosimétrie et d'assurance qualité en radiothérapie et en imagerie médicale (QA), annonce aujourd'hui l'acquisition de PhantomX GmbH, élargis...

 PRESS RELEASE

IBA opens the world of science and technology to secondary school girl...

IBA opens the world of science and technology to secondary school girls Its Innovat’her event brought together female students to explore careers in STEM Louvain-la-Neuve, Belgium, October 17, 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, hosted the Innovat’her event yesterday, aimed at girls in their fifth and sixth years of secondary school. The goal was to introduce them to scientific and technical careers, which remain underrepresented in the academic choices of female students. The event welcomed 25 students, invited by IBA co...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch